• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Gen Meds Leadership Blows

Quote




Anonymous said:
small minded clueless rep

yes leadership blows..sure

thats why our US GenMeds bonus multiplier was 1.5...highest in the world and an all time record


thats why we are 8% ahead of budget this year

baggle pushers all of you
Click to expand...

Or could it be the "success" was driven by Ranbaxy failing to launch generic Diovan????
 




Anonymous said:
SO lacks credibility. he spends the majority of his time working out - never looking at the details of the business, and managing up to PEC. He's great at making a confident speech, being positive about the future, but it's all fluff. There is no detailed planning or thinking. ZERO SUBSTANCE.

I heard he did the same thing in canada. He spent all his time working out and talking big, without ever delivering credible follow up
Click to expand...

Gee, sounds like the clown we have in the White House!
 




















If I hear the word "ownership" one more time, I'm going to puke! Our customers want samples and they want them now. These SRF's suck! Either get behind Exforge 100% or cut the cord already.
 












Top Bottom
Back
Quote